ASX:ICS

ICS Global Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2,000 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield4.33%
BetaN/A

Competitors

ICS Global (ASX:ICS) Vs. 1ST, ALC, BNVIF, CNNA, CNONF, and DOCRF

Should you be buying ICS stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to ICS Global, including 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), and CloudMD Software & Services (DOCRF).

1st Group (ASX:1ST) and ICS Global (ASX:ICS) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, risk, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for 1st Group and ICS Global, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1st Group0000N/A
ICS Global0000N/A

Valuation & Earnings

This table compares 1st Group and ICS Global's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A
ICS Global$6.08 million0.00$1.13 millionA$0.11N/A

ICS Global has higher revenue and earnings than 1st Group.

Profitability

This table compares 1st Group and ICS Global's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1st GroupN/AN/AN/A
ICS GlobalN/AN/AN/A

Summary

ICS Global beats 1st Group on 3 of the 3 factors compared between the two stocks.

Alcidion Group (ASX:ALC) and ICS Global (ASX:ICS) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Alcidion Group and ICS Global, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Alcidion Group0000N/A
ICS Global0000N/A

Profitability

This table compares Alcidion Group and ICS Global's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Alcidion GroupN/AN/AN/A
ICS GlobalN/AN/AN/A

Valuation & Earnings

This table compares Alcidion Group and ICS Global's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alcidion Group$21.55 million0.00$-2,972,082.05A$0.00N/A
ICS Global$6.08 million0.00$1.13 millionA$0.11N/A

ICS Global has lower revenue, but higher earnings than Alcidion Group.

Summary

ICS Global beats Alcidion Group on 2 of the 3 factors compared between the two stocks.

Binovi Technologies (OTCMKTS:BNVIF) and ICS Global (ASX:ICS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends and analyst recommendations.

Earnings and Valuation

This table compares Binovi Technologies and ICS Global's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Binovi TechnologiesN/AN/AN/AN/AN/A
ICS Global$6.08 million0.00$1.13 millionA$0.11N/A

ICS Global has higher revenue and earnings than Binovi Technologies.

Profitability

This table compares Binovi Technologies and ICS Global's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Binovi TechnologiesN/AN/AN/A
ICS GlobalN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings for Binovi Technologies and ICS Global, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Binovi Technologies0000N/A
ICS Global0000N/A

Summary

ICS Global beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

ICS Global (ASX:ICS) and Cann American (CNSX:CNNA) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Earnings & Valuation

This table compares ICS Global and Cann American's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICS Global$6.08 million0.00$1.13 millionA$0.11N/A
Cann AmericanN/AN/AN/AN/AN/A

ICS Global has higher revenue and earnings than Cann American.

Analyst Recommendations

This is a summary of recent ratings and target prices for ICS Global and Cann American, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ICS Global0000N/A
Cann American0000N/A

Profitability

This table compares ICS Global and Cann American's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ICS GlobalN/AN/AN/A
Cann AmericanN/AN/AN/A

Summary

ICS Global beats Cann American on 1 of the 1 factors compared between the two stocks.

CannaOne Technologies (OTCMKTS:CNONF) and ICS Global (ASX:ICS) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for CannaOne Technologies and ICS Global, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CannaOne Technologies0000N/A
ICS Global0000N/A

Profitability

This table compares CannaOne Technologies and ICS Global's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CannaOne TechnologiesN/AN/AN/A
ICS GlobalN/AN/AN/A

Earnings & Valuation

This table compares CannaOne Technologies and ICS Global's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CannaOne TechnologiesN/AN/AN/AN/AN/A
ICS Global$6.08 million0.00$1.13 millionA$0.11N/A

ICS Global has higher revenue and earnings than CannaOne Technologies.

Summary

ICS Global beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

CloudMD Software & Services (OTCMKTS:DOCRF) and ICS Global (ASX:ICS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends.

Earnings & Valuation

This table compares CloudMD Software & Services and ICS Global's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesN/AN/AN/AN/AN/A
ICS Global$6.08 million0.00$1.13 millionA$0.11N/A

ICS Global has higher revenue and earnings than CloudMD Software & Services.

Analyst Recommendations

This is a breakdown of current ratings for CloudMD Software & Services and ICS Global, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services00203.00
ICS Global0000N/A

CloudMD Software & Services currently has a consensus target price of $3.3750, indicating a potential upside of 95.14%.

Profitability

This table compares CloudMD Software & Services and ICS Global's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
ICS GlobalN/AN/AN/A


ICS Global Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1st Group logo
1ST
1st Group
0.5N/AN/A$0.00$5.11 million0.00High Trading Volume
Gap Up
ALC
Alcidion Group
0.5N/AN/A$0.00$21.55 million0.00High Trading Volume
News Coverage
Gap Up
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$0.89flat$0.00N/A0.00Decrease in Short Interest
Gap Down
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.73flat$0.00N/A0.00Decrease in Short Interest
DOC
CloudMD Software & Services
1.2$2.15flatC$0.00C$11.65 million-23.89
CGS
Cogstate
0.5N/AN/A$0.00$28.82 million0.00High Trading Volume
Gap Up
COO
Corum Group
0.5N/AN/A$0.00$12.27 million0.00High Trading Volume
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.12flat$0.00N/A0.00Decrease in Short Interest
News Coverage
EMD
Emyria
0.6N/AN/A$0.00$1.73 million0.00High Trading Volume
Gap Up
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00Gap Up
FORA
Forian
0.3$12.62flat$0.00N/A0.00Gap Up
GLH
Global Health
0.5N/AN/A$0.00$6.77 million0.00High Trading Volume
Gap Up
JHL
Jayex Healthcare
0.7N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
M3 logo
MTHRF
M3
1.0$74.03flat$0.00N/A0.00
M7T
Mach7 Technologies
0.6N/AN/A$0.00$16.89 million0.00High Trading Volume
Gap Up
MDR
MedAdvisor
0.5N/AN/A$0.00$18.09 million0.00High Trading Volume
Gap Up
NEWUF
Newtopia
1.7$0.45flat$0.00N/A0.00Gap Down
NHL
Novita Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ONE
Oneview Healthcare
0.5N/AN/A$0.00$7.10 million0.00High Trading Volume
OPL
Opyl
0.0N/AN/A$0.00$741,494.000.00High Trading Volume
PCK
PainChek
0.0N/AN/A$0.00$240,424.000.00High Trading Volume
PANHF
Ping An Healthcare and Technology
1.0$12.50flat$0.00N/A0.00News Coverage
PKS
PKS
0.0N/AN/A$0.00$5.97 million0.00High Trading Volume
PME
Pro Medicus
0.7N/AN/A$0.00$59.12 million0.00High Trading Volume
Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$33.83flat$0.00N/A0.00Decrease in Short Interest
News Coverage
RAP
ResApp Health
0.9N/AN/A$0.00$46,197.000.00High Trading Volume
Gap Up
CBIIF
Skylight Health Group
0.0$0.96flat$0.00N/A0.00High Trading Volume
Gap Up
TD1
TALi Digital
0.5N/AN/A$0.00$706,550.000.00High Trading Volume
UCBB
US-China Biomedical Technology
0.3$0.13flat$0.00N/A0.00
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$6.16flat$0.00N/A0.00
ZMD
ZoomMed
0.4$0.02flatC$0.00C$10,000.00-1.36Gap Down
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.